Skip to main content

Published locations for Dupilumab under FDA review for atopic dermatitis in children aged 6 months to 5 years

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dupilumab under FDA review for atopic dermatitis in children aged 6 months to 5 years

User login

  • Reset your password
  • /content/dupilumab-under-fda-review-atopic-dermatitis-children-aged-6-months-5-years
  • /clinicianreviews/article/251655/atopic-dermatitis/dupilumab-under-fda-review-atopic-dermatitis
  • /edermatologynews/article/251655/atopic-dermatitis/dupilumab-under-fda-review-atopic-dermatitis
  • /familypracticenews/article/251655/atopic-dermatitis/dupilumab-under-fda-review-atopic-dermatitis
  • /pediatricnews/article/251655/atopic-dermatitis/dupilumab-under-fda-review-atopic-dermatitis-children
  • /pediatrics/article/251655/atopic-dermatitis/dupilumab-under-fda-review-atopic-dermatitis-children
  • /dermatology/article/251655/atopic-dermatitis/dupilumab-under-fda-review-atopic-dermatitis-children
  • /familymedicine/article/251655/atopic-dermatitis/dupilumab-under-fda-review-atopic-dermatitis